3D Printing Financials Q2 2026: Healthcare, Defense, and Dental Drive the Recovery

3D Printing Financials Q2 2026: Healthcare, Defense, and Dental Drive the Recovery

3D Printing

20%
3D Systems aerospace and defense growth vs. flat total revenue
Aerospace & Defense20%
Total Revenue0%

Three publicly traded 3D printing companies reported Q2 2026 results, and the picture they paint is consistent: the industry’s recovery is real, but it is happening in specific verticals rather than across the board. Healthcare, aerospace and defense, and dental applications are growing at double-digit rates. Everything else is flat to declining.

The Numbers

3D Systems (NYSE: DDD) posted Q2 revenue of $94.6 million, flat year-over-year in aggregate. Within that flat headline number, healthcare grew 6.8%, aerospace and defense grew more than 20%, and data center infrastructure applications also grew more than 20%. Metal and polymer printer sales both showed double-digit unit growth. Adjusted EBITDA improved to a near-breakeven loss of $0.8 million from a $4.7 million loss in the prior year period. Q3 guidance is $96-99 million. The company also announced the departure of CEO Jeffrey Graves.

Prodways (EPA: ALPWG) grew Q2 revenue 5% year-over-year (adjusted for divestitures) to €10.5 million. Its Systems division — which sells printers — grew 9%, driven by ceramic printer demand in the U.S. market. The company returned €20 million to shareholders through a buyback following the sale of its software division, and expects stable to improving profitability in the second half.

Align Technology (Nasdaq: ALGN) is the largest of the three by revenue. Q2 came in just over $1.05 billion, up 4.3% year-over-year. Clear aligner revenue grew 8.2% and shipments hit a record at approximately 692,000 cases. The offset: Imaging Systems and CAD-CAM Services fell 10.8% as dental customers shift toward lower-priced scanners or leasing models rather than outright purchases.

What It Signals

The common thread across all three reports is sector specificity. 3D printing is not recovering uniformly — it is recovering where the value proposition is clearest and the alternatives are least competitive. Healthcare remains the strongest segment because patient-specific geometries, complex internal structures, and small-batch production requirements align with what additive manufacturing does better than any alternative. Aerospace and defense growth reflects both increased defense spending and the maturation of metal AM qualification for critical components.

The Align results are a useful data point in the other direction. In dental, a segment where 3D printing has become commoditized, customers are optimizing for cost rather than for capability — which puts pressure on hardware margins and shifts value toward consumables and recurring services. That pressure will likely appear across other application areas as the technology matures and the competitive set expands.

The So What

For anyone making capital allocation decisions about 3D printing investments — whether in equipment, services, or equities — the Q2 results reinforce a selection principle: follow the verticals with the strongest defensibility. Healthcare, aerospace, and defense applications have structural reasons to continue growing. Industrial tooling and prototyping applications face more pricing pressure. The industry recovery is not a rising tide; it is a pattern of specific applications reaching commercial maturity while others commoditize.

Source: 3DPrint.com

Content created with AI assistance and reviewed for accuracy.

💬

Join the conversation

Stack Insiders is our free community for readers who want to go deeper — share resources, ask questions, and connect with others across every vertical we cover.

Join Stack Insiders →

Newsletter coming soon.

Curated digests across AI, biohacking, photography, travel, and more. Be the first to know when we launch.